GYRO Form 4/A: Insider exercised rights for 8,698 shares; ownership corrected

Rhea-AI Filing Summary

Gyrodyne, LLC director Ronald J. Macklin filed an amended Form 4 showing an insider transaction dated 03/12/2024. The filing reports the acquisition of 8,698 common shares through exercise of rights in a rights offering at a price of $8 per share, and records 30,441 shares beneficially owned following the transaction. The amendment corrects the number of shares acquired and the number beneficially owned as noted in the filing. The document is an amended disclosure of previously reported insider activity.

Positive

• Amended filing corrects share counts, improving disclosure accuracy
• Insider acquired 8,698 common shares via exercise of rights at $8 per share

Negative

• Initial report contained incorrect share counts, necessitating an amendment

Insights

Securities Analyst

TL;DR: Routine amended insider filing correcting share counts after an exercise of rights; no new securities sold.

This amended Form 4 discloses a director-level insider exercise of rights that resulted in 8,698 common shares acquired at $8 each and a post-transaction beneficial ownership of 30,441 shares. The amendment explicitly states corrections to both the number of shares acquired and the number beneficially owned, which improves disclosure accuracy for investors. There is no indication of derivative transactions or dispositions in this filing.

Corporate Governance Expert

TL;DR: Filing shows corrective disclosure by a director; transparency enhanced but no material change to control.

The report is an amended Section 16 filing by a director, indicating compliance with insider reporting obligations and correcting prior numeric errors. The underlying activity was an exercise of rights from a rights offering, not a sale, and the signature date on the form is 08/27/2025. The filing does not present governance issues beyond the need for correction of prior reporting details.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MACKLIN RONALD J

(Last) (First) (Middle)

1 FLOWERFIELD, SUITE 24

(Street)

ST. JAMES NY 11780

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gyrodyne, LLC [ GYRO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/12/2024

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTS	03/12/2024		J(1)		8,698(2)	A	$8	30,441(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquired shares through exercise of rights pursuant to rights offering of the issuer

2. Corrected the number of shares acquired in this Form 4

3. Corrected the number of shares beneficially owned in this Form 4

	Ronald Macklin	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ronald J. Macklin report on the amended Form 4 for GYRO?

The amended Form 4 reports that Ronald J. Macklin acquired 8,698 common shares by exercise of rights and beneficially owns 30,441 shares after the transaction.

When was the transaction that triggered the Form 4 amendment for GYRO?

The transaction date reported is 03/12/2024 and the Form 4 amendment corrects previously reported numbers.

At what price were the shares acquired in the GYRO Form 4 amendment?

The filing states the shares were acquired at a price of $8 per share through exercise of rights.

Does the amended Form 4 report any sales or derivative transactions for GYRO?

No; the filing reports an acquisition via exercise of rights and contains no derivative securities or dispositions.

Who signed the amended Form 4 and when?

The signature block shows Ronald Macklin and a signature date of 08/27/2025.